Medical Care Technologies Inc Stock Price, News & Analysis

Medical Care Technologies (OTC:MDCE) has unveiled its innovative AI Facial Health Risk Estimator, a technology designed to detect early cardiovascular disease risks through advanced facial imaging analysis.

The system employs deep neural networks to analyze biometric markers including micro-wrinkle density, skin elasticity, and tone variations. By comparing biological age against chronological age, the platform can identify cardiovascular predisposition before clinical symptoms appear, offering a non-invasive alternative to traditional testing methods.

Medical Care Technologies (OTC:MDCE) has unveiled an innovative AI platform for detecting squamous cell carcinoma (SCC), the second most common form of skin cancer. The technology employs advanced machine learning classifiers to identify early warning signs that might be missed during self-examinations.

The AI system utilizes edge-detection algorithms and keratin pattern recognition to identify various SCC indicators including rough patches, persistent lesions, and early ulcerations. A key feature is its ability to differentiate SCC from precancerous conditions through longitudinal comparison modeling, tracking lesion evolution across the entire body.

Medical Care Technologies (OTC:MDCE) has launched an innovative AI platform designed for early detection of basal cell carcinoma (BCC), the most common type of skin cancer. The platform enables at-home screening and monitoring through advanced texture and reflectance analysis technology.

The AI system features sophisticated capabilities including pearly nodule identification, vascular pattern recognition, ulceration tracking, and pixel-level texture classification to distinguish between benign growths and potential carcinomas. This technology aims to address the limited access to dermatology services by providing accessible, non-invasive screening solutions.

Medical Care Technologies (OTC:MDCE) has unveiled a groundbreaking AI platform for early melanoma detection. The technology leverages deep learning algorithms trained on millions of dermatoscopic and clinical images to analyze key melanoma risk factors including asymmetry, border irregularities, color variations, diameter, and evolution monitoring.

The AI system creates longitudinal profiles of moles and lesions, flagging anomalies before progression. This advancement is particularly significant as melanoma, while representing only 1% of skin cancers, causes the majority of skin cancer deaths. When detected early, melanoma survival rates exceed 95%.

Medical Care Technologies (OTC Pink:MDCE) announced that its subsidiary Infinite Auctions LLC has secured a $2.54 million sports memorabilia inventory. The collection includes high-value assets such as a LeBron James 2016 NBA Finals game-worn jersey valued at nearly $1 million and a rare Tom Brady 1/1 card worth potentially hundreds of thousands based on recent comparable sales.

The company is leveraging these liquid assets to support its primary mission of developing AI-powered healthcare diagnostics across multiple verticals including mental health tracking, wound monitoring, and melanoma detection. The strategic move aims to provide financial flexibility for R&D and accelerate the commercialization of its AI healthcare platform.

Medical Care Technologies (OTC:MDCE) reported that its subsidiaries have generated over $1 million in revenue before Q3 2025's end. Infinite Auctions achieved significant sales, including a LeBron James NBA Finals jersey for $242,000, while Real Game Used generated $58,948 from authentication services.

The company plans to use this revenue to achieve a debt-free balance sheet by year-end and fund its AI healthcare technology development. MDCE's roadmap includes advancing patent applications, refining AI health screening models, completing beta testing, publishing case studies, and preparing for FDA submissions.

Medical Care Technologies (OTC PINK:MDCE) has announced its projection to achieve debt-free status by the end of Q4 2025, driven by strong performance from its subsidiaries. The company's two main revenue generators, Infinite Auctions LLC (sports memorabilia auction house) and Real Game Used LLC (AI-powered authentication platform), have reported robust sales growth.

MDCE has also filed a U.S. provisional patent application for an AI-driven diagnostic platform that aims to transform smartphones into preventive healthcare screening tools, capable of detecting conditions like melanoma, wound infections, and mental health disorders. The company plans to leverage its improving financial position to advance this healthcare technology initiative.

Medical Care Technologies (OTC PINK:MDCE) announced a significant reduction in its share structure as CEO Marshall Perkins voluntarily surrendered 680 million shares of common stock back to the company's treasury. The company's authorized share count remains at approximately 8 billion shares.

MDCE operates in AI healthcare and sports authentication through its subsidiaries Infinite Auctions and Real Game Used. The company is developing a patent-pending AI health diagnostics platform targeting the global healthcare market, which is projected to exceed $1 trillion by 2030.

Medical Care Technologies (OTC PINK:MDCE) has unveiled its AI Facial Age-Based Health Risk Estimator, an innovative technology that analyzes facial features to predict health risks and biological age. The system utilizes advanced analysis of micro-wrinkle density, skin elasticity, and tonal gradients to generate real-time health insights.

The company is targeting the digital health and longevity market, which is projected to reach $1 trillion globally by 2030. The technology will be integrated into MDCE's beta app, scheduled for release in 2026. CEO Marshall Perkins III emphasized the technology's potential to revolutionize preventative healthcare and wellness management.